Product Code: ETC088667 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Indonesia radiopharmaceutical market has seen steady growth in recent years due to the country?s rising healthcare expenditure, growing demand for advanced medical technologies and treatments, and an expanding aging population. The COVID-19 outbreak is likely to have a limited impact on the market as most of the activities are still being carried out by major players in this sector.
The government has taken several initiatives such as providing tax exemptions on medicines and medical equipment used in nuclear medicine diagnostics, which will further drive the growth of the Indonesia radiopharmaceutical market during the forecast period.
The increasing prevalence of cancer and other chronic diseases coupled with advancements such as PET/CT scans that use radiopharmaceuticals drives greater demand for these products. Additionally, government initiatives to expand healthcare infrastructure throughout Indonesia offer a favorable environment for further investment from both local and foreign companies operating in this field. This will lead to improved accessibility of radiopharmaceuticals in remote areas of the country. Furthermore, ongoing developments in product formulations also contribute significantly towards driving up sales revenues for existing players as well as creating opportunities for new entrants into this domain.
The COVID-19 pandemic had led to disruption across all industries including healthcare leading to reduced business operations which affects supply chain management systems globally thus impacting availability of radiopharmaceuticals within Indonesia among other disruptions caused by travel restrictions etc. However it should be noted that despite short term disruptions ,the long term prospects remain largely positive given rising healthcare expenditure trends.
Radiophamaceutcials require special handling during production process due their hazardous nature resulting therefor high operational costs associated with them. Additionally their low shelf life adds additional cost burden on producers / suppliers who need frequent replenishment cycles at higher frequency than normal drugs or pharmaceutical products.Furthermore stringent regulations imposed by governing bodies makes entry difficult into this market segment especially when compared against traditional drug markets making it harder fpr new entrantes.
Leading players currently operating within Indonesia Radiopharmaceutical industry include PT Bintang Medika Asia (BMA), PT Nusindo Abadi Samapta (NAS) & PT Anugerah Pharmasi Indomulya (API). These firms benefit from strong relationships established with hospitals across Indonesia through dedicated marketing efforts and distribution networks developed over time allowing these companies hold significant share within domestic market
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Radiopharmaceutical Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Radiopharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Radiopharmaceutical Market - Industry Life Cycle |
3.4 Indonesia Radiopharmaceutical Market - Porter's Five Forces |
3.5 Indonesia Radiopharmaceutical Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Indonesia Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Indonesia Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2021 & 2031F |
3.8 Indonesia Radiopharmaceutical Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Indonesia Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Indonesia Radiopharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Radiopharmaceutical Market Trends |
6 Indonesia Radiopharmaceutical Market, By Types |
6.1 Indonesia Radiopharmaceutical Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Radiopharmaceutical Market Revenues & Volume, By Types, 2018 - 2031F |
6.1.3 Indonesia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2018 - 2031F |
6.1.4 Indonesia Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2018 - 2031F |
6.2 Indonesia Radiopharmaceutical Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2018 - 2031F |
6.2.3 Indonesia Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2018 - 2031F |
6.3 Indonesia Radiopharmaceutical Market, By Procedural Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2018 - 2031F |
6.3.3 Indonesia Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2018 - 2031F |
6.4 Indonesia Radiopharmaceutical Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2018 - 2031F |
6.4.3 Indonesia Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2018 - 2031F |
6.5 Indonesia Radiopharmaceutical Market, By End-users |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.5.3 Indonesia Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2018 - 2031F |
6.5.4 Indonesia Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2018 - 2031F |
6.5.5 Indonesia Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2018 - 2031F |
6.5.6 Indonesia Radiopharmaceutical Market Revenues & Volume, By Others, 2018 - 2031F |
7 Indonesia Radiopharmaceutical Market Import-Export Trade Statistics |
7.1 Indonesia Radiopharmaceutical Market Export to Major Countries |
7.2 Indonesia Radiopharmaceutical Market Imports from Major Countries |
8 Indonesia Radiopharmaceutical Market Key Performance Indicators |
9 Indonesia Radiopharmaceutical Market - Opportunity Assessment |
9.1 Indonesia Radiopharmaceutical Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Indonesia Radiopharmaceutical Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 Indonesia Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2021 & 2031F |
9.4 Indonesia Radiopharmaceutical Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Indonesia Radiopharmaceutical Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Indonesia Radiopharmaceutical Market - Competitive Landscape |
10.1 Indonesia Radiopharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |